New hope for myeloma patients as platform trial tests multiple treatments
NCT ID NCT05583617
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 36 times
Summary
This study is testing several new drug combinations for people with multiple myeloma, a type of blood cancer. The trial is open to 200 participants who have already had some treatment. The goal is to see if these combinations are safe and help control the disease. Because multiple myeloma often requires ongoing treatment, this study focuses on disease control rather than a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Lyon Sud - Service Hématologie
RECRUITINGPierre-Bénite, 69310, France
-
Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hopital Bretonneau
RECRUITINGTours, 37044, France
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Universitari Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08915, Spain
-
IGR
WITHDRAWNVillejuif, 94800, France
-
IUCT Oncopole
RECRUITINGToulouse, 31059, France
-
Oddzial Kliniczny Hematologii SPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie
RECRUITINGOlsztyn, 10-228, Poland
-
Prince of Wales Hospital
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
St Vincent's Hospital Melbourne
RECRUITINGFitzroy, Victoria, 3065, Australia
-
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II
RECRUITINGHamburg, 20246, Germany
-
Universitätsklinikum Leipzig - Klinik und Poliklinik für Hämatologie
RECRUITINGLeipzig, 04103, Germany
-
Uniwersytecki Szpital Kliniczny w Poznaniu
WITHDRAWNPóźna, 60-569, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGda?sk, 80-214, Poland
Conditions
Explore the condition pages connected to this study.